Biotech's twentieth birthday blues

Nature Reviews Drug Discovery

Volumn 2, Issue 3, 2003, Pages 231-233

  Miska, David ^a  

^a Medbase LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ARTICLE; BIOTECHNOLOGY; FOOD AND DRUG ADMINISTRATION; INDUSTRY; MEDICAL RESEARCH; PRIORITY JOURNAL; DRUG DESIGN; DRUG INDUSTRY; NOTE; PHILOSOPHY; UNITED STATES;

BIOTECHNOLOGY; DRUG DESIGN; DRUG INDUSTRY; PHILOSOPHY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0037364331     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1036     Document Type: Article

References (10)

1. Miller, H. I. As biotech turns 20... Nature Rev. Drug Discov 2, 1007-1008 (2002).
2. Mises, L. Bureaucracy (Libertarian, Spring Mills, Pennsylvania, 1996).
3. Fernandes, M. & Miska, D. The role of governance in drug development. Scrip Magazine, pp10-11 (November 2002).
4. Watson, J. D. & Crick, F. H. C. A structure for deoxyribose nucleic acid. Nature 171, 737-738 (1953).
5. Henderson, R. & Cockburn, I. Firm size and research productivity in drug disvovery. [online] (cited 12 Jan 03) (Jan 1997).
6. Horrobin, D. F. Commercialization of biotechnology: might Cassandra be right? Presented at 53rd Mosbach Kolloquium, Mosbach, Baden (April 2002).
7. Demain, A. F. Prescription for an ailing pharmaceutical industry. Nature Biotechnol. 20, 331 (2002).
8. Le Fanu, J. The Rise and Fall of Modern Medicine (Carroll & Graff, New York, 1999).
9. Lewontin, R. The Triple Helix: Gene, Organism, and Environment (Harvard University Press, Cambridge, Massachussetts, 2000).
10. Gold, T. New ideas in science. J. Sci. Explor. 3, 103-112 (1989).